Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 263,861 | 18,016 | 5,117 | 32 | -88,881 |
| Depreciation Amortization | -2,942 | -2,245 | -1,873 | -1,052 | -10,227 |
| Accounts receivable | -36,806 | -21,312 | -21,295 | -13,987 | -22,698 |
| Other Working Capital | 11,530 | -5,885 | -22,834 | -62,132 | -10,127 |
| Other Operating Activity | 111,726 | 66,835 | 54,670 | 49,622 | 79,913 |
| Operating Cash Flow | $347,369 | $55,409 | $13,785 | $-27,517 | $-52,020 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,593 | 70,910 | 56,544 | 27,238 | 53,717 |
| PPE Investments | -1,918 | -1,666 | -322 | -143 | -1,124 |
| Other Investing Activity | -6,183 | 550 | 0 | 0 | 0 |
| Investing Cash Flow | $-13,694 | $69,794 | $56,222 | $27,095 | $52,593 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -22,883 | -132,253 | N/A | N/A | N/A |
| Debt Repayment | -325,386 | -3,802 | -75,714 | -516 | N/A |
| Common Stock Issued | 9,174 | 8,494 | 5,826 | 2,396 | 3,478 |
| Other Financing Activity | -10,836 | -4,410 | -3,269 | -1,351 | -9,239 |
| Financing Cash Flow | $-349,931 | $-131,971 | $-73,157 | $529 | $-5,761 |
| Exchange Rate Effect | 1,270 | 1,342 | 1,810 | 451 | -936 |
| Beginning Cash Position | 106,323 | -14,840 | -15,058 | 106,323 | 112,447 |
| End Cash Position | 91,337 | -20,266 | -16,398 | 106,881 | 106,323 |
| Net Cash Flow | $-14,986 | $-5,426 | $-1,340 | $558 | $-6,124 |
| Free Cash Flow | |||||
| Operating Cash Flow | 347,369 | 55,409 | 13,785 | -27,517 | -52,020 |
| Capital Expenditure | -2,468 | -1,666 | -322 | -143 | -1,124 |
| Free Cash Flow | 344,901 | 53,743 | 13,463 | -27,660 | -53,144 |